[Discrepancy in histopathological findings of curettage material and hysterectomy specimens in malignant tumors of the uterine body].
The clinical staging of the malignoma of the uterine corpus according to the FIGO classification corresponds in only 85.7% in stage I and 35.7% in stage II to the histopathologic staging after operation. Tumor grading and histology from D and C differ in 31.8% and 9.4% respectively from the hysterectomy specimen. We propose therefore to prefer surgical and histopathological staging to the pure clinical FIGO-staging in order to plan adjuvant therapy and for comparing therapeutic results of different patient groups as well.
Hänggi
W
W
Universitäts-Frauenklinik Bern.
Katz
M
M
Fravi
R
R
König
C
C
Dreher
E
E
D000230:Adenocarcinoma / Q000473:pathology* / Q000601:surgery / Q000628:therapy; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004107:Dilatation and Curettage; D005260:Female; D006801:Humans; D007044:Hysterectomy; D008875:Middle Aged; D009367:Neoplasm Staging; D010347:Patient Care Planning; D014594:Uterine Neoplasms / Q000473:pathology* / Q000601:surgery / Q000628:therapy
Diskrepanz der histopathologischen Befunde von Kürettagematerial und Hysterektomiepräparat beim Malignom des Corpus uteri.